⌘K

Login Start Free

Home/Filings/4/0001104659-23-046893

4//SEC Filing

Orlinger Klaus 4

Accession 0001104659-23-046893

CIK 0001760542other

View on SEC.gov Company Profile

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 7:50 PM ET

Size

5.4 KB

Accession

0001104659-23-046893

Insider Transaction Report

Form 4

Period: 2023-04-14

HOOKIPA Pharma Inc.HOOK

Sr. VP, Research

Transactions

Award
Stock Option (Right to Buy)
2023-04-14+194,200→ 194,200 total
Exercise: $1.00Exp: 2033-04-14→ Common Stock (194,200 underlying)

Footnotes (1)

[F1]25% of this option shall vest on February 15, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file

4
tm2312963-6_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother

Related Parties

1

filerCIK 0001768432

Filing Metadata

Form type: 4
Filed: Apr 17, 8:00 PM ET
Accepted: Apr 18, 7:50 PM ET
Size: 5.4 KB

View on SEC.gov